New York Mets' Robinson Cano banned for year due to PED

Tanya Simon
November 19, 2020

Robinson Cano has been suspended for the entire 2021 season after testing positive for a performance-enhancing drug, Major League Baseball announced Wednesday.

Cano, who turned 38 in October, is under contract through the 2023 season earning $24 million a season.

According to the joint drug agreement between Major League Baseball and the MLB Players Association, a second positive test means that a player is automatically suspended for 162 games.

There was no immediate comment from Cano or the players' union.

US Senate blocks confirmation of Donald Trumps Federal Reserve nominee
A second Fed board vacancy could be filled in the coming weeks by another Trump nominee, Christopher Waller, the St. Party-line votes for Fed board positions haven't occurred before, reflecting the institution's apolitical nature.

After the 2018 season, Cano was traded to the Mets. The Mariners were on the tab to pay $3.75 million of that salary, with the Mets set to take on $20.25 million. He's an eight-time All-Star and two-time Gold Glove victor. Cano became a star with the New York Yankees before signing with the Mariners. Cano also received an 80-game ban in 2018 when he tested positive for a different substance that he said was given to him by a licensed doctor in the Dominican Republic.

Cano has forfeited $35.7 million in salary for the two suspensions.

Minus Cano, New York could move good-hitting Jeff McNeil into a regular spot at second base. McNeil has played all over the infield and outfield while batting.319 in three seasons with the Mets.

Other reports by

Discuss This Article